Daytime Sleepiness (Credit: Canva)
Experiencing daytime sleepiness is something that is usually perceived as a minor inconvenience, but for older adults, it could be an early warning sign of Dementia. This neurodegenerative disease leads to the progressive decline of brain cells. This eventually
affects memory, cognition, and personality, making everyday tasks more difficult. As one of the fastest-growing neurological disorders across the world, dementia poses a significant health threat to ageing populations.
For this study, researchers followed 445 older adults (average age 76) over three years, aiming to determine whether poor sleep could increase the risk of mild cognitive impairment (MCI), which often leads to dementia. At the start, none of the participants had MCI, but by the end of the study, 36 individuals had developed the condition.
The researchers discovered that participants with poor sleep were more likely to develop MCI compared to those who slept well. However, when depression symptoms were taken into account, the link between poor sleep and MCI became less pronounced, suggesting that while sleep issues are a concern, mental health also plays a key role in dementia risk.
To assess sleep quality, the Pittsburgh Sleep Quality Index (PSQI) was used, evaluating factors such as sleep duration, disturbances, and daytime alertness. Among these, "daytime dysfunction"—defined as excessive sleepiness and low energy during the day—was most strongly associated with an increased risk of MCI. Those experiencing daytime dysfunction were more than three times as likely to develop MCI as those who didn’t report such symptoms.
There are many types of dementia:
Dementia is not a specific disease. According to the Centers for Disease Control and Prevention (CDC), it is an overall term that describes a decline in mental ability that interferes with daily life. People with dementia often have symptoms like trouble remembering, thinking, or making everyday decisions. These symptoms tend to get worse over time.
Alzheimer’s disease is the most common type of dementia, and it mostly affects the elderly. Each form of dementia has a different cause. Though dementia mostly affects older adults, it is not a part of normal ageing. An estimated 6.7 million older adults have Alzheimer's disease in the United States. That number is expected to double by 2060, as per data from the CDC.
In 2022, 3.8% of men and 4.2% women in US were diagnosed with dementia. The percentage of people increase with age from 1.7% for those aged 65-74 to 13.1% for those aged 85 and older. Alzheimer's accounts for 60 to 80% of all dementia cases and it is most prevalent in California, Florida, and Texas, as these states have the highest number of people.
Credit: AI
With H1N1 outbreak expanding in Delhi, India is witnessing an overwhelming increase in seasonal influenza cases. To compound to the public health issue, the flu vaccine that best matches the viruses currently circulating in the country is facing a supply shortage.
Therefore, the Indian Council of Medical Research (ICMR) has advised that another seasonal influenza vaccine can be used temporarily until the one preferred becomes available again.
The ICMR recommendation comes after influenza surveillance found that viruses circulating in India have a closer match with the strains included in this year’s Northern Hemisphere (NH) vaccine.
However, the Southern Hemisphere (SH) vaccine, which is available in India, can still provide protection against several viruses circulating in the country.
According to ICMR, the NH vaccine would be the ideal choice because its composition closely matches the influenza viruses currently detected in India.
ICMR said, “Since the surveillance data indicates close resemblance of the circulating influenza strains in India with the Northern Hemisphere recommendations of WHO, it would be ideal to administer the NH vaccine.”
“However, in view of non-availability of NH vaccine, the available SH vaccine may be used, and SH vaccine be replaced with NH vaccine as soon as it becomes available,” it added.
According to several reports, the shortage is starting to affect hospital supplies, including government supply of the preferred vaccine.
The surge in demand, production timelines, limited imports and redistribution of vaccines globally could be the factors driving the shortage currently.
Also read: ICMR Study Shows Pune Dengue Mosquitoes Resistant To Insecticides: What It Means for Public Health
The current H1N1 virus circulating in India can be tackled by both the NH and SH vaccines. The difference is primarily in the strains of the other influenza viruses they target, particularly H3N2 and influenza B.
ICMR surveillance has detected H1N1, H3N2 and influenza B viruses circulating in India. The NH vaccine contains versions of H3N2 and influenza B that more closely match the strains currently being detected.
India's National Centre for Disease Control has also previously advised that when the latest recommended seasonal formulation is unavailable, the latest available trivalent or quadrivalent influenza vaccine may be used.
Also read: 98 Years After Penicillin, Are We Running Out Of Effective Antibiotics?
People who are at higher risk of severe influenza, doctors say that said it may not be necessary to remain unvaccinated while waiting for the NH vaccine.
These include older adults, young children, pregnant women and people with chronic illnesses or weak immune system. Influenza can cause complications like pneumonia and can worsen existing medical conditions in vulnerable people.
HealthandMe spoke to Dr. Divya K S, Infectious Disease Specialist at Apollo Hospitals, Seshadripuram, Bangalore, about the efficacy of SH vaccine on H1N1. The doctor also explained if one should wait for NH vaccine.
The doctor explains, “People should take the Southern Hemisphere vaccine which is available for now rather than wait. Because waiting now means leaving people with no protection at all while active flu season is on. Bothe the vaccines do have some components in common. So taking the SH vaccine does give protection
The expert also clarified if SH vaccine offers complete adequate coverage on current H1N1 strain.
She added, “On H1N1 specifically, the SH vaccine offers full expected protection, because the H1N1 strain — A/Missouri/11/2025-like virus — is identical in both the NH and SH formulations this season. it is H3N2. B/Victoria strains that are different from the NH vaccine.”
India's influenza surveillance network continually tracks circulating strains and helps determine which vaccine is likely to offer the best match. This year's ICMR assessment is why the NH formulation is preferred, but the SH vaccine still remains a practical alternative while supplies are limited. Experts recommend taking it instead of staying unprotected.
Credit: iStock
One of the most effective ways to prevent rabies deaths could be by vaccinating dogs rather than just people before they are bitten. A new study published in The Lancet Regional Health – Southeast Asia modelled different strategies in Kerala for eradicating human rabies deaths between 2026 and 2035.
The study found that mass vaccination of dogs could bring the annual rabies deaths among people in Kerala close to zero within about three years even if 70% of the dog population were vaccinated.
On the other hand, vaccinating children before exposure to rabies was projected to prevent relatively few additional deaths at substantially higher cost.
India carries one of the worst largest rabies burdens. That's why the study could point towards a feasible and practical solution to eradicate the deadly infection.
Most human rabies deaths in India are linked to bites from infected dogs. This means that the disease can be tackled at its source by reducing transmission among dogs.
India records an estimated 9.1 million animal bites every year, with more than three-quarters caused by dogs. A 2024 estimate from the Indian Council of Medical Research's National Institute of Epidemiology estimates India's annual human rabies deaths to be about 5,726, which is an alarming public health issue.
The study puts emphasis on the fact that vaccinating a person after a bite protects that individual, whereas, vaccinating dogs reduces the probability that an infected dog will transmit rabies to many people in the first place.
Researchers from the University of Glasgow, Kerala's health and animal-husbandry departments, Kerala University of Health Sciences and the London School of Economics and Political Science used mathematical modelling to compare different strategies to combat rabies in Kerala.
One strategy was routine pre-exposure prophylaxis (PrEP) for children. Another focused on mass dog vaccination, while the model also considered improvements to post-exposure prophylaxis (PEP), the treatment given after a potentially rabid bite.
The researchers found that adding routine childhood PrEP provided minimal additional protection, preventing fewer than 10 deaths on average over a decade, while costing considerably more than strategies focused on controlling rabies transmission among dogs.
The model estimated that achieving 70% vaccination coverage among dogs could reduce annual human rabies deaths in Kerala to near zero within approximately three years.
Also read: Abhayrab Rabies Vaccine Batch Found Misbranded, ‘Not Of Standard Quality’: DCGI Alerts States
One of the study's striking findings was about the size of Kerala's stray-dog population. The researchers' modelling suggested that the state's actual stray-dog population could be around five times higher than official census estimates.
If vaccination programmes are based on an underestimated dog population, authorities could believe they have reached adequate coverage while a large proportion of dogs remain unvaccinated. That creates what epidemiologists call an immunity gap, allowing rabies transmission to continue.
Additionally, dog vaccination does not make human post-exposure treatment unnecessary. If a person is bitten or scratched by an animal that could have rabies, the wound should be washed thoroughly with soap and running water and medical care should be sought immediately.
Depending on the exposure, PEP can include rabies vaccine and rabies immunoglobulin (RIG). This is particularly important because rabies becomes extremely difficult to treat once symptoms begin.
The study also found that improving timely access to PEP could prevent more deaths than expanding routine pre-exposure vaccination of children.
Credit: X
The death of Lady Joan Branson, wife of billionaire entrepreneur Sir Richard Branson, has highlighted the risk of a blood clot after fractures that travels to the lungs.
Lady Branson, 80, died at Lister Hospital in London in November 2025 after being admitted following a fall at her home on Necker Island. An inquest heard that she had developed a deep vein thrombosis (DVT) and subsequently suffered a massive pulmonary embolism (PE).
The coroner, Professor Fiona Wilcox, concluded that her death could probably have been prevented if anti-clotting treatment had been given earlier. She said: “If this lady had been given [anti-clotting medication] early on ... her death, on the balance of probability, would have been prevented.”
What exactly happens after a fracture that can make a blood clot so dangerous?
A fracture can trigger several conditions that encourage the development of venous thromboembolism (VTE), the collective term for DVT and PE.
First, injury itself activates the body's clotting system. The body naturally increases clot formation after tissue damage to prevent bleeding.
Second, a person with a fracture may become significantly less mobile. When the leg muscles are not moving normally, the muscle pump that helps push blood through the veins becomes less effective. Blood can therefore pool in the deep veins, particularly in the legs. Hospitalisation, surgery, older age, previous blood clots and certain medical conditions can add further risk.
A clot that remains in a leg vein can cause swelling and pain. But when part of it breaks and gets away, it can travel through the bloodstream to the lungs, leading to a pulmonary embolism.
Also read: 9/11 Toxic Air Exposed Thousands: What New Records Reveal 25 Years Later
A clot forming in a deep vein, usually in the leg, can detach and travel through the veins into the right side of the heart. From there, it can enter the pulmonary arteries, which carry blood to the lungs.
If the clot is large enough, it can obstruct blood flow through the lungs and suddenly increase pressure on the right side of the heart.
A large or massive PE can therefore cause severe breathlessness, low blood pressure, cardiac arrest and sudden death.
This is why PE can sometimes appear dramatically, even when the original DVT produced few obvious symptoms.
According to the inquest, Lady Branson had a history of blood clots dating back to 2010, and doctors heard evidence that she had previously used anti-clotting injections.
However, she was not given enoxaparin, a low-molecular-weight heparin commonly used to prevent or treat harmful blood clots, during her hospital stay.
One doctor, Dr Inaki Bovill, told the inquest that a venous thromboembolism risk assessment should have been carried out and that the medication should have been prescribed. He said: “It is to my great regret that I did not.”
Another doctor, Dr George Adams, a consultant haematologist at Imperial College London, told the inquest that earlier anticoagulation would have made cardiac arrest less likely in her particular case.
Lady Branson's daughter, Dr Holly Branson, disputed the suggestion that her mother had refused the injections because of previous pain or bruising. She told the inquest that this was “not consistent with my knowledge of her usual practice or attitude.”
A DVT can cause:
A PE may cause:
© $2026 Times Horizon Private Limited